ArticleNeuroscience applied2023
Deep Transcranial Magnetic Stimulation in combination with symptom provocation: An effective treatment in patients with treatment-resistant Body Dysmorphic Disorder?
Article in Neuroscience applied, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Body dysmorphic disorder: Diagnostic challenges and current management.JAAPA : official journal of the American Academy of Physician Assistants · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Body Dysmorphic Disorder (BDD) concerns an excessive preoccupation concerning a perceived physical defect, associated with function impairment. No FDA-approved treatment exists for BDD, and many patients are resistant to standard treatment. Neuromodulation, especially deep Transcranial Magnetic Stimulation (dTMS) represents an important option in treating resistant patients in the obsessive-compulsive spectrum. No previous studies adopted dTMS in BDD. In this case series we reported the cases of three patients with resistant BDD treated with dTMS in combination with symptom provocation, a cognitive-behavioural therapy technique. Symptoms severity decreased after the treatment in all the three patients. These preliminary data suggested that dTMS plus symptom provocation could be an effective treatment for treatment resistant BDD patients. Further prospective studies are needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.